We are willing to litigate our CRISPR patents, says IP chief on the CVC side
ERS Genomics’ Michael Arciero shares his views on the Cas9 licensing landscape in an exclusive IAM interview
ERS Genomics’ Michael Arciero shares his views on the Cas9 licensing landscape in an exclusive IAM interview
Commission may face legal challenges but risks of trade secrets breaches and increased litigation abound
Unleashing American Innovators in, Pride in Patent Ownership out of bill which is expected to hit Biden’s desk on Friday
Companies who scored the most from US juries during the past 12 months include VLSI Technology, Complete Genomics Inc, Ravgen Inc, USAA and Columbia University
19 December 2022
Controversial Pride in Patent Ownership bill unlikely, other bills passed or possible
16 December 2022
Qualcomm executive and Invent Together director discuss initiatives at IP Dealmakers conference in New York
13 December 2022
Selling revenue streams is an increasingly important way of monetising pharma innovations
16 November 2022
Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line
04 November 2022
As the sovereign patent fund closes down, CEO Didier Patry shares his thoughts with IAM readers on the organisation’s work over the past decade
03 November 2022
The role of the technology transfer office is crucial for getting products to market. Implementing well thought-out strategies will allow these to flourish in your organisation.
19 October 2022
Company chief economist Kirti Gupta speaks with IAM about how better to assess leadership in the wireless and semiconductor industries
12 October 2022
Third-party backing is at an all-time high, but questions linger over how much should be public
07 October 2022
Saturday Opinion: Without a coherent approach to capturing domestic value from R&D including greater clarity on subject matter patentability, the positive consequences of higher US government funding will be felt as much in Berlin, Bangalore and Beijing as Boston
24 September 2022
Unlock unlimited access to all IAM content